Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening - Concepedia

Concepedia

Publication | Open Access

Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening

DOI Full Paper Access

125

Citations

31

References

2017

Year

Maria Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo, Rucsandra Dobrotă, J. L. Corona Hernandez, Roger Hesselstrand, Cecília Varjú, Gabriella Nagy, Vanessa Smith, Paola Caramaschi,

The Journal of Rheumatology

Abstract

Anti-RNAP3+ patients with SSc have a high risk of concomitant malignancy. These results have implications for clinical practice and suggest regular screening for cancer in anti-RNAP3+ patients.

References

	Year	Citations

Page 1